Results 221 to 230 of about 79,407 (254)
Some of the next articles are maybe not open access.
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
The Lancet, 2013 P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert, I. Jacobson, M. Washington, G. Germanidis, John F Flaherty, R. Schall, J. Bornstein, K. Kitrinos, G. Subramanian, J. Mchutchison, E. Heathcote +14 moresemanticscholar +1 more sourceEfficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Lancet, The, 2021 Shahin Lockman, Lynda Stranix-Chibanda, Lee Fairlie +2 moreexaly Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study.
The Lancet Gastroenterology and Hepatology, 2020 P. Lampertico, M. Buti, S. Fung, S. Ahn, W. Chuang, W. Tak, A. Ramji, Chiyi Chen, E. Tam, H. Bae, Xiaoli Ma, John F Flaherty, A. Gaggar, A. Lau, Yang Liu, George Y Wu, V. Suri, Susanna K. Tan, G. Subramanian, H. Trinh, S. Yoon, K. Agarwal, Y. Lim, H. Chan +23 moresemanticscholar +1 more sourceEfficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load
Hepatology International, 2021 B. Li, Zhaozhe Liu, Xing Liu, Dongchun Liu, Mingyu Duan, Ye Gu, Qiong Liu, Qiang Ma, Yushi Wei, Yan A Wang +9 moresemanticscholar +1 more source
